Usually rhinosinusitis (RS) is more common than any other chronic disease in the US, with nearly 35 million cases occurring annually, according to 1998 statistics from the Centers for Disease Control and Prevention (CDC). This number does not include the 20 million annual cases of acute RS. Effective treatment of RS and other upper respiratory tract infections (URTIs) is significantly impeded by emerging bacterial resistance to antibiotics.